Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 16;18(1):17.
doi: 10.1186/s12906-018-2083-2.

Herbal formula YGJDSJ inhibits anchorage-independent growth and induces anoikis in hepatocellular carcinoma Bel-7402 cells

Affiliations

Herbal formula YGJDSJ inhibits anchorage-independent growth and induces anoikis in hepatocellular carcinoma Bel-7402 cells

Bing Hu et al. BMC Complement Altern Med. .

Abstract

Background: Based on clinical medications and related studies, we established a Yang-Gan Jie-Du Sang-Jie (YGJDSJ) herbal formula for hepatocarcinoma treatment. In present study, we evaluated the anti-cancer potential of YGJDSJ on suspension-grown human hepatocellular carcinoma Bel-7402 cells.

Methods: Bel-7402 cells were cultured in poly(2-hydroxyethyl methacrylate) (poly-HEMA) coated plates and treated with YGJDSJ. Anchorage-independent cell growth was detected by cell Counting Kit-8 (CCK-8) assay and soft agar colony formation assay. Anoikis was detected by ethdium homodimer-1 (EthD-1) staining and flow cytometry analysis. Caspases activities were detected by the cleavage of chromogenic substrate. Reactive oxygen species (ROS) was detected by 2',7'-dichlorofluorescin diacetate (DCFH-DA) staining. Protein expression and phosphorylation was identified by western blot. Protein expression was knocked-down by siRNA.

Results: YGJDSJ inhibited the proliferation of Bel-7402 cells in poly-HEMA coated plates and anchorage-independent growth of Bel-7402 cells in soft agar. YGJDSJ also induced anoikis in Bel-7402 cells as indicated by EthD-1 staining and flow cytometry analysis. YGJDSJ activated caspase-3, - 8, and - 9 in suspension-grown Bel-7402 cells. The pan-caspase inhibitor Z-VAD-FMK significantly abrogated the effects of YGJDSJ on anoikis in suspension-grown Bel-7402 cells. In addition, YGJDSJ increased ROS in suspension-grown Bel-7402 cells. The ROS scavenger N-acetyl-L-cysteine (NAC) partially attenuated YGJDSJ-induced activation of caspase-3, - 8 and - 9 and anoikis in suspension-grown Bel-7402 cells. Furthermore, YGJDSJ inhibited expression and phosphorylation of protein tyrosine kinase 2 (PTK2) in suspension-grown Bel-7402 cells. Over-expression of PTK2 significantly abrogated YGJDSJ induced anoikis.

Conclusions: YGJDSJ inhibits anchorage-independent growth and induce caspase-mediated anoikis in Bel-7402 cells, and may relate to ROS generation and PTK2 downregulation.

Keywords: Anoikis; Caspases; Chinese herb; Hepatocellular carcinoma; Protein tyrosine kinase 2; Reactive oxygen species.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
YGJDSJ inhibited anchorage-independent growth of Bel-7402 cells. a Bel-7402 cells were cultured in poly-HEMA coated 96-well plate and treated with different concentrations of YGJDSJ for 24 h, cell viability was evaluated by CCK-8 assay. b Bel-7402 cells were treated with different dose of YGJDSJ twice a week for 2 weeks in soft-agar colony formation assay. Data shown are representative of three independent experiments. *P < 0.01, versus control group
Fig. 2
Fig. 2
YGJDSJ induced anoikis in Bel-7402 cells. Suspension-grown Bel-7402 cells were treated with different dose of YGJDSJ for 24 h, stained with EthD-1, and observed under fluorescence microscope (× 200) (a), and quantitated with a fluorescence microplate reader (b). YGJDSJ treated or untreated Bel-7402 cells were stained with Annexin V-FITC/PI, analyzed in FACScalibour flow cytometer (c), and expressed as mean ± SD (d). Data illustrated are from three separate experiments. *P < 0.01, versus control group
Fig. 3
Fig. 3
YGJDSJ activated caspases in Bel-7402 cells. After 24 h YGJDSJ (100–400 μg/ml) treatment, caspase-3 (a), caspase-3 (b) and caspase-9 (c) activities in suspension-cultured Bel-7402 cells were detected as described in Materials and Methods. Caspases activities were expressed as fold activation over control. d suspension-cultured Bel-7402 cells were pretreated with Z-VAD-FMK (50 μmol/L) for 2 h before treatment with YGJDSJ for 24 h, stained with Annexin V-FITC/PI and analyzed by flow cytometry. Data presented are from three separate experiments. *P < 0.01, versus control group; #P < 0.01, versus corresponding dose of YGJDSJ treated Z-VAD-FMK (−) group
Fig. 4
Fig. 4
YGJDSJ increased ROS level in Bel-7402 cells. After 24 h YGJDSJ (100–400 μg/ml) treatment, intracellular ROS production in suspension-cultured Bel-7402 cells was stained with DCFH-DA, observed under fluorescence microscope (× 200) (a), quantitated with a fluorescence microplate reader and expressed as fold of control (b) Suspension-cultured Bel-7402 cells were pretreated with NAC (50 mmol/L for 2 h) for ROS inhibition, followed by YGJDSJ (100–400 μg/ml) treatment for 24 h, and subjected to caspase-3 (c), caspase-8 (d) and caspase-9 (e) activities and anoikis detection (f). Caspases activities were expressed as fold activation over control. Data shown are representative of three independent experiments. *P < 0.01, versus control group; #P < 0.01, versus corresponding dose of YGJDSJ treated NAC (−) group.
Fig. 5
Fig. 5
YGJDSJ inhibited PTK2 expression and phosphorylation in Bel-7402 cells. Suspension-cultured Bel-7402 cells were collected after YGJDSJ treatment, subjected to western blots using indicated antibodies (a), and the expression of proteins were expressed as fold of GAPDH (b). Bel-7402 cells were transfected with recombinant human PTK2 and empty vector, and subjected to suspension-culture, YGJDSJ (200 μg/ml) treatment for 24 h, western blots using indicated antibodies (c) and anoikis detection (d). *P < 0.01, versus control group; P > 0.05, versus control YGJDSJ group; #P < 0.01, versus YGJDSJ treated vector group

Similar articles

Cited by

References

    1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi: 10.3322/caac.21262. - DOI - PubMed
    1. Grandhi MS, Kim AK, Ronnekleiv-Kelly SM, Kamel IR, Ghasebeh MA, Pawlik TM. Hepatocellular carcinoma: from diagnosis to treatment. Surg Oncol. 2016;25(2):74–85. doi: 10.1016/j.suronc.2016.03.002. - DOI - PubMed
    1. Zhuang L, Wen T, Xu M, Yang J, Wang W, Wu H, et al. Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma. Arch Med Sci. 2017;13(6):1383–1393. doi: 10.5114/aoms.2017.71066. - DOI - PMC - PubMed
    1. Duseja A. Staging of hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4(Suppl 3):S74–S79. doi: 10.1016/j.jceh.2014.03.045. - DOI - PMC - PubMed
    1. Yüksel Ş, Boylu Akyerli C, Cengiz Yakıcıer M. Angiogenesis, invasion, and metastasis characteristics of hepatocellular carcinoma. J Gastrointest Cancer. 2017; 10.1007/s12029-017-9962-5. - PubMed

MeSH terms